Carvana is up 15% After JPMorgan Upgrade – Did They Miss These 3 Red Flags?
Early this morning Carvana surged 15% before leveling off and dipping back down a bit. However, this is the first positive price movement the online vehicle retailer has seen in quite some time. The reason for this quick jump? The stock was upgraded from “underweight” to “neutral” by an analyst at JPMorgan. While most analysts - and investors - [...]
Actinium Pharmaceuticals (ATNM) Jumps 39% After Trial Results – Here’s What Investors Should Do…
Actinium Pharmaceuticals (ATNM) is one of the biggest movers early Monday morning. The stock is up 39% for the day after the firm released news that their latest trial results were more than optimistic. The company specializes in developing targeted therapies for cancer. Their therapies are known as antibody radiation conjugates - a special treatment that leverages the targeting [...]
Nuvalent Gains 50%+ After Positive Trial Results – Is This Reason Enough to Buy?
As of 11 AM EST Friday morning, Nuvalent has gained over 50% on its share price. The stock topped out at around $38/share (a 75% gain) but has started to trend back downwards and currently sits at $33/share. What happened to cause this spike? The company creates precisely targeted cancer treatments designed to overcome the limitations of existing [...]
Shopify’s Q3 Earnings Report is a Step in the Right Direction…but is it Time to Buy Yet?
Shopify has made moves this morning after reporting Q3 earnings that were better than anticipated. So far, the cloud-based eCommerce platform is up 18% as of 1:30 pm EST. And while this is definitely a step in the right direction, investors and analysts alike are still not sure the time is quite right for Shopify.Nevertheless, after 6 quarters of continuously [...]
Wingstop Jumps 20% – Here are 2 Things Investors Need to Weigh Before Making a Move
Early this morning Wingstop stock shares jumped over 20% and are counting, making them one of the market's biggest movers. This came as a result of an impressive Q3 earnings report alongside full-year earnings guidance. The company raised estimations after posting better-than-expected earnings in the third quarter - and investors have responded positively. A huge reason for Wingstop’s excellent [...]
TSHA Stock Soars 56%+ on Astella Deal…But Here are 3 Issues Investors Need to See
The biggest mover so far this morning on the stock market is TSHA - Taysha Gene Therapy. They’re making huge moves up almost 50% before noon EST. If you’re not yet familiar with this company, the name alone tells you that they're engaged in gene therapy. But more specifically, they engage in the development and commercialization of adeno-associated viruses [...]
